Literature DB >> 16034051

Enrolling older persons in cancer trials: the effect of sociodemographic, protocol, and recruitment center characteristics.

Cary P Gross1, Jeph Herrin, Natalie Wong, Harlan M Krumholz.   

Abstract

PURPOSE: To determine the effect of patient, protocol, geographic, and institutional factors on enrollment of older persons onto cancer trials.
METHODS: We conducted a cross-sectional analysis of patients enrolled onto National Cancer Institute-sponsored lung, breast, colorectal, and prostate cancer trials during 1996 to 2002. We used a cross-classified logistic multilevel model to examine the associations between patient, hospital, county, and protocol characteristics, and the likelihood of participants being elderly (>or= 65 years old).
RESULTS: The final study sample consisted of 36,167 patients enrolled onto 33 trials. After accounting for cancer type, only 6% of the variation in elderly enrollment onto cancer trials was at the protocol level. In contrast, more than 55% of the variation in elderly enrollment was attributable to patient level variation. In multivariate analysis, nonwhite patients were significantly less likely to be elderly than whites (odds ratio [OR] for blacks, 0.51; 95% CI, 0.44 to 0.58; and OR for Hispanics, 0.49; 95% CI, 0.40 to 0.59 v whites). Participants living less than 7 miles from their recruitment center were significantly more likely to be elderly (OR, 1.31; 95% CI, 1.24 to 1.38). Among the 910 recruitment centers, the median adjusted proportion of patients who were elderly was 24.9% (interquartile range, 24.0% to 26.9%). There were a significantly higher number of outlier centers (<or= 20.8% or >or= 29.3% elderly) than would be expected by a normal distribution (68 observed v six expected; P < .0001).
CONCLUSION: Race and proximity to trial enrollment centers were significantly related to age of trial participants after adjusting for protocol factors. Additional work should explore why some recruitment centers were outliers regarding enrollment of older persons.

Entities:  

Mesh:

Year:  2005        PMID: 16034051     DOI: 10.1200/JCO.2005.14.365

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  27 in total

1.  Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA.

Authors:  Walter Stummer; Ulf Nestler; Florian Stockhammer; Dietmar Krex; Bodo C Kern; Hubert M Mehdorn; Giles H Vince; Uwe Pichlmeier
Journal:  J Neurooncol       Date:  2010-10-05       Impact factor: 4.130

2.  Demographic and other characteristics of nodal non-Hodgkin's lymphoma managed in academic versus non-academic centers.

Authors:  Vijaya Raj Bhatt; Prajwal Dhakal; Sumit Dahal; Smith Giri; Ranjan Pathak; R Gregory Bociek; Peter T Silberstein; James O Armitage
Journal:  Ther Adv Hematol       Date:  2015-10

3.  Effects of chemotherapy on survival of elderly patients with small-cell lung cancer: analysis of the SEER-medicare database.

Authors:  Laura C Caprario; David M Kent; Gary M Strauss
Journal:  J Thorac Oncol       Date:  2013-10       Impact factor: 15.609

4.  Policies to address disparities in clinical trials: the EDICT Project.

Authors:  Cynthia A Spiker; Armin D Weinberg
Journal:  J Cancer Educ       Date:  2009       Impact factor: 2.037

5.  Making the invisible visible: professional education to eliminate disparities in clinical trials.

Authors:  Larry Laufman
Journal:  J Cancer Educ       Date:  2009       Impact factor: 2.037

Review 6.  Surgical management of high-grade glioma: a standard of care.

Authors:  Colin Watts
Journal:  CNS Oncol       Date:  2012-11

Review 7.  Treating glioblastoma in the elderly.

Authors:  Jaime Gállego Pérez-Larraya; Jean-Yves Delattre
Journal:  CNS Oncol       Date:  2012-11

8.  Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry.

Authors:  Marije E Hamaker; Reinhard Stauder; Barbara C van Munster
Journal:  Oncologist       Date:  2014-08-28

9.  Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic.

Authors:  Lydia T Madsen; Deborah A Kuban; Seungtaek Choi; John W Davis; Jeri Kim; Andrew K Lee; Delora Domain; Larry Levy; Louis L Pisters; Curtis A Pettaway; John F Ward; Christopher Logothetis; Karen E Hoffman
Journal:  J Natl Compr Canc Netw       Date:  2014-07       Impact factor: 11.908

10.  Differences in clinical trial patient attributes and outcomes according to enrollment setting.

Authors:  Elizabeth B Lamont; Mary Beth Landrum; Nancy L Keating; Laura Archer; Lan Lan; Gary M Strauss; Rogerio Lilenbaum; Harvey B Niell; L Herbert Maurer; Michael P Kosty; Antonius A Miller; Gerald H Clamon; Anthony D Elias; Edward F McClay; Everett E Vokes; Barbara J McNeil
Journal:  J Clin Oncol       Date:  2009-11-23       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.